HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Gniadecki Selected Research

Skin Diseases (Skin Disease)

4/2021Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond.
7/2017A randomized, double-blind, placebo-controlled, dose-escalation first-in-man study (phase 0) to assess the safety and efficacy of topical cytosolic phospholipase A2 inhibitor, AVX001, in patients with mild to moderate plaque psoriasis.
11/2012Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Gniadecki Research Topics

Disease

21Psoriasis (Pustulosis Palmaris et Plantaris)
06/2022 - 07/2007
8Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2021 - 08/2006
7Necrosis
05/2016 - 05/2003
4Psoriatic Arthritis
01/2019 - 11/2012
3Cardiovascular Diseases (Cardiovascular Disease)
06/2022 - 02/2013
3Skin Diseases (Skin Disease)
04/2021 - 11/2012
3Atopic Dermatitis (Atopic Eczema)
01/2021 - 07/2010
3Pemphigus (Pemphigus Vulgaris)
01/2021 - 10/2006
3Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa)
01/2021 - 12/2015
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2021 - 01/2014
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021 - 01/2014
3Systemic Scleroderma (Systemic Sclerosis)
01/2021 - 01/2014
3Carcinogenesis
02/2013 - 02/2000
2Inflammation (Inflammations)
06/2022 - 03/2017
2Infections
04/2021 - 01/2018
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021 - 12/2020
2Oral Lichen Planus
01/2021 - 12/2020
2Crohn Disease (Crohn's Disease)
01/2021 - 12/2020
2Skin Neoplasms (Skin Cancer)
03/2013 - 08/2003
2Mycosis Fungoides
03/2013 - 03/2000
1Atherosclerosis
06/2022
1COVID-19
04/2021
1Bronchiolitis Obliterans Syndrome
12/2020
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2019
1Obesity
01/2019
1Myocardial Infarction
12/2018
1Joint Diseases (Joint Disease)
07/2017
1Melanoma (Melanoma, Malignant)
02/2013
1Pruritus (Itching)
11/2012
1Arthralgia (Joint Pain)
11/2012
1Fatigue
11/2012
1Lymphomatoid Papulosis
04/2008
1Lymphoma (Lymphomas)
04/2008
1Primary Cutaneous Anaplastic Large Cell Lymphoma
04/2008
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
04/2008
1Autoimmune Diseases (Autoimmune Disease)
10/2006
1Blister (Bulla)
10/2006
1Acantholysis
10/2006
1Hypothyroidism
08/2006
1Erythema
02/2002
1Basal Cell Carcinoma (Rodent Ulcer)
12/2000
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2000

Drug/Important Bio-Agent (IBA)

10Biological ProductsIBA
06/2022 - 10/2000
6Adalimumab (Humira)FDA Link
08/2018 - 05/2011
5Pharmaceutical PreparationsIBA
01/2019 - 05/2011
5Ustekinumab (CNTO 1275)FDA Link
01/2018 - 09/2011
5Etanercept (Enbrel)FDA Link
01/2018 - 05/2011
4Proteins (Proteins, Gene)FDA Link
11/2012 - 12/2000
3Interleukin-12 (IL 12)IBA
01/2018 - 06/2015
3Infliximab (Remicade)FDA Link
01/2018 - 05/2011
3secukinumabIBA
01/2018 - 07/2017
2Methotrexate (Mexate)FDA LinkGeneric
01/2019 - 02/2013
2Monoclonal AntibodiesIBA
07/2017 - 07/2010
2MicroRNAs (MicroRNA)IBA
03/2017 - 02/2013
2Bexarotene (LGD1069)FDA Link
09/2007 - 08/2006
1guselkumabIBA
05/2021
1Cardiovascular AgentsIBA
12/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018
1InterferonsIBA
01/2018
1Biosimilar PharmaceuticalsIBA
01/2018
1Phospholipases A2 (Phospholipase A2)IBA
07/2017
1PLIalphaIBA
07/2017
1AVX001IBA
07/2017
1EnzymesIBA
07/2017
1Ubiquitin-Specific ProteasesIBA
03/2017
1NF-kappa B (NF-kB)IBA
03/2017
1AntibodiesIBA
05/2016
1Immunoglobulin M (IgM)IBA
12/2015
1Furocoumarins (Furanocoumarins)IBA
03/2013
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
03/2013
1Proteasome Endopeptidase Complex (Proteasome)IBA
03/2013
1RNA (Ribonucleic Acid)IBA
02/2013
1Cyclin-Dependent Kinase Inhibitor p16IBA
02/2013
1ametantrone (HAQ)IBA
11/2012
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
11/2012
1efalizumab (Raptiva)FDA Link
07/2010
1Formaldehyde (Formol)FDA Link
04/2008
1ParaffinIBA
04/2008
1LigandsIBA
04/2008
1Phosphotransferases (Kinase)IBA
04/2008
1Alefacept (Amevive)FDA Link
07/2007
1DesmogleinsIBA
10/2006
1AutoantibodiesIBA
10/2006
1RetinoidsIBA
08/2006
1ThapsigarginIBA
08/2003
1CalciumIBA
08/2003
1calcipotriene (calcipotriol)FDA LinkGeneric
02/2002
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2000
1Interleukin-2 Receptor alpha SubunitIBA
03/2000
1DNA (Deoxyribonucleic Acid)IBA
02/2000

Therapy/Procedure

10Therapeutics
04/2021 - 08/2006
3Photopheresis
01/2021 - 01/2014
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2021 - 01/2014
2Organ Transplantation
01/2021 - 12/2020
2Biological Therapy
12/2018 - 01/2015
1Immunotherapy
04/2021
1Phototherapy (Light Therapy)
03/2013
1Contraindications
09/2011
1Withholding Treatment
08/2006
1Lasers (Laser)
03/2000